 Clinical experience aztreonam treatment infections children vitro activity pharmacokinetics bactericidal activity tissue penetration aztreonam role therapy serious gram-negative bacterial infections children Several children world aztreonam open comparative clinical trials treatment infections pyelonephritis bacteremia meningitis skeletal infection pneumonia peritonitis Cure rates relapses children obstructive renal lesions infections Salmonella comparative trial aztreonam treatment neonatal sepsis effective amikacin infection Aztreonam clinical results comparable conventional combined therapy pulmonary infection patients cystic fibrosis Adverse effects pediatric trials uncommon fever diarrhea rash treated children Reversible laboratory abnormalities basis data aztreonam appropriate alternative agent treatment serious gram-negative bacterial infections neonates children Further comparative clinical trials specific indications